Merck & Co.
Search results
175 Years of Pfizer Breakthroughs. We’re celebrating 175 years of daring scientific innovation—and we’re not done yet. Every day, we’re channeling our passion and resources into delivering innovative therapies that change the face of healthcare. Let’s outdo yesterday. Follow our progress as we accelerate the next generation of cancer ...
- Careers
Depending on the customs and laws of a specific country,...
- Products
In this section find an overview of our Pfizer Products and...
- Contact Us
The Pfizer Board Policies Ensuring ethical leadership...
- Investors Overview
Forward-Looking Statements of Pfizer Inc. This transcript...
- Newsroom
04.22.2024 Prescription Medicines Medicines European...
- Executives
Terramycin also marks the beginning of the Pfizer...
- Announcements
02.23.2024 Diversity & Inclusion Employees Responsibility...
- Updates and Statements
10.25.2023 Vaccines Pfizer’s PENBRAYA™ Receives...
- About
Pfizer purchases a nearby vacant ice plant, and employees...
- Careers
Dec 11, 2020 · COMIRNATY is the first COVID-19 vaccine to be granted FDA approval Approval is based on a comprehensive submission package including six-month efficacy and safety data after second dose More than 1.2 billion Pfizer-BioNTech doses have been delivered to more than 120 countries or territories around the world since December 2020 Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today ...
The headquarters of Pfizer in Tokyo, Japan. Pfizer Inc. ( / ˈfaɪzər / FY-zər) [3] is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer (1824–1906) and his cousin Charles ...
- c. 83,000 (2022)
- 1849; 174 years ago in New York City
- US$100.3 billion (2022)
- The Spiral, New York City, U.S.
10.26.2023 Pfizer and BioNTech Announce Positive Topline Data for mRNA-based Combination Vaccine Program Against Influenza and COVID-19 Pfizer Inc. and BioNTech SE today announced positive topline results from a Phase 1/2 study (NCT05596734) evaluating the safety, tolerability and immunogenicity of mRNA-based combination vaccine candidates for influenza and COVID-19 among healthy adults 18 to ...
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, [2] [32] is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech. For its development, BioNTech collaborated with the American company Pfizer to carry out clinical trials, logistics, and manufacturing. [44] [45] It is authorized for use ...
- Comirnaty
- mRNA
Aug 23, 2021 · Since Dec. 11, 2020, the Pfizer-BioNTech COVID-19 Vaccine has been available under EUA in individuals 16 years of age and older, and the authorization was expanded to include those 12 through 15 ...
Sep 22, 2021 · Since Dec. 11, 2020, the Pfizer-BioNTech COVID-19 Vaccine has been available under EUA for individuals 16 years of age and older. The authorization was expanded on May 10, 2021 to include those 12 ...
